Steven Reichling - 08 Mar 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Financial Officer
Signature: /s/ Steve Reichling
Issuer symbol: AXDX
Transactions as of: 08 Mar 2023
Transactions value $: -$29,506
Form type: 4
Filing time: 13 Mar 2023, 17:46:22 UTC
Previous filing: 15 Feb 2023
Next filing: 15 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+124K	+160.9%	$0.00	200K	08 Mar 2023	Direct	F1
transaction	AXDX	Common Stock	Sale	-$29.5K	-62.8K	-31.32%	$0.47	138K	08 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-124K	-100%	$0.00^*	0	08 Mar 2023	Common Stock	124K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 123,600 restricted stock units, which vested in full on March 8, 2023.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.